Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1980 Jul 5;123(1):26–31.

Familial pseudohypoparathyroidism without somatic anomalies.

J S Winter, I A Hughes
PMCID: PMC1704543  PMID: 6251958

Abstract

A family is described in which affected individuals showed pseudohypoparathyroidism, with hypocalcemia, hyperphosphatemia and increased serum levels of parathyroid hormone, but none of the somatic anomalies frequently associated with this disorder. The untreated individuals showed radiologic evidence of osteitis fibrosa. The administration of parathyroid hormone evoked only a slight increase in the excretion of cyclic adenosine monophosphate but no change in the renal tubular reabsorption of phosphate and no rise in the serum calcium level. The infusion of ethylenediamine tetra-acetic acid caused an appropriate increase in the serum level of parathyroid hormone, but again there was no apparent renal or skeletal response to the hormone. There were no associated abnormalities in calcitonin, thyrotropin or prolactin levels and no thyroid dysfunction. Therapy with vitamin D corrected the hypocalcemia but did not improve the renal and skeletal responsiveness to parathyroid hormone. The inheritance of the disorder in this family was compatible with an autosomal dominant mode with variable penetrance, but other modes could not be excluded.

Full text

PDF
28

Images in this article

27FIG. 2
on p.27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aurbach G. D., Marcus R., Winickoff R. N., Epstein E. H., Jr, Nigra T. P. Urinary excretion of 3',5'-AMP in syndromes considered refractory to parathyroid hormone. Metabolism. 1970 Oct;19(10):799–808. doi: 10.1016/0026-0495(70)90077-6. [DOI] [PubMed] [Google Scholar]
  2. Bijvoet O. L., Morgan D. B., Fourman P. The assessment of phosphate reabsorption. Clin Chim Acta. 1969 Oct;26(1):15–24. doi: 10.1016/0009-8981(69)90280-0. [DOI] [PubMed] [Google Scholar]
  3. Bijvoet O. L. Renal phosphate excretion in man. Folia Med Neerl. 1972;15(2):84–93. [PubMed] [Google Scholar]
  4. COSTELLO J. M., DENT C. E. HYPO-HYPERPARATHYROIDISM. Arch Dis Child. 1963 Aug;38:397–407. doi: 10.1136/adc.38.200.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carlson H. E., Brickman A. S., Bottazzo G. F. Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med. 1977 Jan 20;296(3):140–144. doi: 10.1056/NEJM197701202960304. [DOI] [PubMed] [Google Scholar]
  6. Chase L. R., Melson G. L., Aurbach G. D. Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest. 1969 Oct;48(10):1832–1844. doi: 10.1172/JCI106149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Connors M. H., Irias J. J., Golabi M. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone. Pediatrics. 1977 Sep;60(3):343–348. [PubMed] [Google Scholar]
  8. Drezner M. K., Neelon F. A., Haussler M., McPherson H. T., Lebovitz H. E. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab. 1976 Apr;42(4):621–628. doi: 10.1210/jcem-42-4-621. [DOI] [PubMed] [Google Scholar]
  9. Drezner M., Neelon F. A., Lebovitz H. E. Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal. N Engl J Med. 1973 Nov 15;289(20):1056–1060. doi: 10.1056/NEJM197311152892003. [DOI] [PubMed] [Google Scholar]
  10. Frame B., Hanson C. A., Frost H. M., Block M., Arnstein A. R. Renal resistance to parathyroid hormone with osteitis fibrosa: "pseudohypohyperparathyroidism". Am J Med. 1972 Mar;52(3):311–321. doi: 10.1016/0002-9343(72)90018-6. [DOI] [PubMed] [Google Scholar]
  11. Gertner J. M., Tomlinson S., Gonzalez-Macias J. Normocalcaemic pseudohypoparathyroidism with unusual phenotype. Arch Dis Child. 1978 Apr;53(4):312–315. doi: 10.1136/adc.53.4.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Haddad J. G., Chyu K. J. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971 Dec;33(6):992–995. doi: 10.1210/jcem-33-6-992. [DOI] [PubMed] [Google Scholar]
  13. Haussler M. R., McCain T. A. Basic and clinical concepts related to vitamin D metabolism and action (second of two parts). N Engl J Med. 1977 Nov 10;297(19):1041–1050. doi: 10.1056/NEJM197711102971906. [DOI] [PubMed] [Google Scholar]
  14. KOLB F. O., STEINBACH H. L. Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa. J Clin Endocrinol Metab. 1962 Jan;22:59–70. doi: 10.1210/jcem-22-1-59. [DOI] [PubMed] [Google Scholar]
  15. Kooh S. W., Fraser D., DeLuca H. F., Holick M. F., Belsey R. E., Clark M. B., Murray T. M. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med. 1975 Oct 23;293(17):840–844. doi: 10.1056/NEJM197510232931702. [DOI] [PubMed] [Google Scholar]
  16. Marx S. J., Hershman J. M., Aurbach G. D. Thyroid dysfunction in pseudohypoparathyroidism. J Clin Endocrinol Metab. 1971 Nov;33(5):822–828. doi: 10.1210/jcem-33-5-822. [DOI] [PubMed] [Google Scholar]
  17. McDonald K. M. Responsiveness of bone to parathyroid extract in siblings with pseudohypoparathyroidism. Metabolism. 1972 Jun;21(6):521–531. doi: 10.1016/0026-0495(72)90096-0. [DOI] [PubMed] [Google Scholar]
  18. Nusynowitz M. L., Frame B., Kolb F. O. The spectrum of the hypoparathyroid states: A classification based on physiologic principles. Medicine (Baltimore) 1976 Mar;55(2):105–119. doi: 10.1097/00005792-197603000-00001. [DOI] [PubMed] [Google Scholar]
  19. Rodriguez H. J., Villarreal H., Jr, Klahr S., Slatopolsky E. Pseudohypoparathyroidism type II: restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J Clin Endocrinol Metab. 1974 Oct;39(4):693–701. doi: 10.1210/jcem-39-4-693. [DOI] [PubMed] [Google Scholar]
  20. Steiner A. L., Kipnis D. M., Utiger R., Parker C. Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate. Proc Natl Acad Sci U S A. 1969 Sep;64(1):367–373. doi: 10.1073/pnas.64.1.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stögmann W., Fischer J. A. Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D. Am J Med. 1975 Jul;59(1):140–144. doi: 10.1016/0002-9343(75)90332-0. [DOI] [PubMed] [Google Scholar]
  22. Tashijan A. H., Jr, Howland B. G., Melvin K. E., Hill C. S., Jr Immunoassay of human calcitonin. N Engl J Med. 1970 Oct 22;283(17):890–895. doi: 10.1056/NEJM197010222831702. [DOI] [PubMed] [Google Scholar]
  23. Weinberg A. G., Stone R. T. Autosomal dominant inheritance in Albright's hereditary osteodystrophy. J Pediatr. 1971 Dec;79(6):996–999. doi: 10.1016/s0022-3476(71)80196-8. [DOI] [PubMed] [Google Scholar]
  24. Werder E. A., Fischer J. A., Illig R., Kind H. P., Bernasconi S., Fanconi A., Prader A. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract. J Clin Endocrinol Metab. 1978 Jun;46(6):872–879. doi: 10.1210/jcem-46-6-872. [DOI] [PubMed] [Google Scholar]
  25. Zisman E., Lotz M., Jenkins M. E., Bartter F. C. Studies in pseudohypoparathyroidism. Two new cases with a probable selective deficiency of thyrotropin. Am J Med. 1969 Mar;46(3):464–471. doi: 10.1016/0002-9343(69)90048-5. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES